Biora Therapeutics Inc Market Cap ($994.99K)
Market Cap & Net Worth: Biora Therapeutics Inc (BIOR)
Biora Therapeutics Inc market cap. Biora Therapeutics Inc (NASDAQ:BIOR) has a market capitalization of $994.99K ($994.99K) as of October 31, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30691 globally and #6247 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biora Therapeutics Inc's stock price $0.22 by its total outstanding shares 4522700 (4.52 Million).
Biora Therapeutics Inc Market Cap History (2020–2026)
Biora Therapeutics Inc market cap history from 2020 to 2026. Data shows change from $6.00 Billion to $994.99K (-81.08% CAGR). Check BIOR stock price for real-time trading data and today's change.
Biora Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biora Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see BIOR cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
15264.11x
Biora Therapeutics Inc's market cap is 15264.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $6.00 Billion | $74.31 Million | -$192.53 Million | 80.79x | N/A |
| 2021 | $2.36 Billion | $1.25 Million | -$178.52 Million | 1895.04x | N/A |
| 2022 | $149.25 Million | $305.00K | -$38.16 Million | 489.34x | N/A |
| 2023 | $61.06 Million | $4.00K | -$124.11 Million | 15264.11x | N/A |
Competitor Companies of BIOR by Market Capitalization
Companies near Biora Therapeutics Inc in the global market cap rankings as of October 31, 2026. See Biora Therapeutics Inc balance sheet quality to understand what proportion of total assets are financed by equity.
Key companies related to Biora Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Biora Therapeutics Inc (2020–2026)
Market capitalization of Biora Therapeutics Inc from 2020 to today. Between 2020 and today, Biora Therapeutics Inc's market cap moved from $6.00 Billion to $ 994.99K, with a yearly change of -81.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $994.99K | 0.00% |
| 2025 | $994.99K | 0.00% |
| 2024 | $994.99K | -98.37% |
| 2023 | $61.06 Million | -59.09% |
| 2022 | $149.25 Million | -93.68% |
| 2021 | $2.36 Billion | -60.64% |
| 2020 | $6.00 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Biora Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $994.99K USD |
| MoneyControl | $994.99K USD |
| MarketWatch | $994.99K USD |
| marketcap.company | $994.99K USD |
| Reuters | $994.99K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Biora Therapeutics Inc
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-fre… Read more